| Literature DB >> 32426239 |
Satheeswaran Balasubramanian1, Kanmani Gunasekaran1, Saranyadevi Sasidharan1, Vignesh Jeyamanickavel Mathan1, Ekambaram Perumal1.
Abstract
The advent of new technologies has paved the rise of various chemicals that are being employed in industrial as well as consumer products. This leads to the accumulation of these xenobiotic compounds in the environment where they pose a serious threat to both target and non-target species. miRNAs are one of the key epigenetic mechanisms that have been associated with toxicity by modulating the gene expression post-transcriptionally. Here, we provide a comprehensive view on miRNA biogenesis, their mechanism of action and, their possible role in xenobiotic toxicity. Further, we review the recent in vitro and in vivo studies involved in xenobiotic exposure induced miRNA alterations and the mRNA-miRNA interactions. Finally, we address the challenges associated with the miRNAs in toxicological studies.Entities:
Keywords: ADAMTS9, A disintegrin and metalloproteinase with thrombospondin motifs 9; AHR, Aryl Hydrocarbon Receptor; AMPK, Adenosine Monophosphate-activated protein kinase; ARRB1, Arrestin beta 1; Ag, Silver; Al2O3, Aluminium oxide; Au, Gold; Aβ, Amyloid Beta; BCB, Blood-cerebrospinal fluid barrier; BNIP3−3, BCL2/adenovirus E1B 19 kDa protein-interacting protein 3; BaP, Benzo[a]pyrene; Biomarkers; CCNB1, Cyclin B1; CDC25A, M-phase inducer phosphatase 1; CDC25C, M-phase inducer phosphatase 3; CDK, Cyclin-dependent Kinase; CDK1, Cyclin-dependent kinase 1; CDK6, Cyclin-dependent kinase 6; CDKN1b, Cyclin-dependent kinase Inhibitor 1B; CEC, Contaminants of Emerging Concern; COPD, Chronic obstructive pulmonary disease; COX2, Cyclooxygenase-2; CTGF, Connective Tissue Growth Factor; DGCR8, DiGeorge syndrome chromosomal [or critical] region 8; DNA, Deoxy ribonucleic acid; DON, Deoxynivalenol; ER, Endoplasmic Reticulum; Environment; Epigenetics; Fadd, Fas-associated protein with death domain; GTP, Guanosine triphosphate; Gene regulation; Grp78/BIP, Binding immunoglobulin protein; HSPA1A, Heat shock 70 kDa protein 1; Hpf, Hours post fertilization; IL-6, Interleukin 6; IL1R1, Interleukin 1 receptor, type 1; LIN28B, Lin-28 homolog B; LRP-1-, Low density lipoprotein receptor-related protein 1; MAPK, Mitogen Activated Protein Kinase; MC-LR, Microcystin-Leucine Arginine; MC-RR, Microcystin-Arginine Arginine; MRE, MicroRNA Response Elements; Mn, Manganese; NASH, Non-alcoholic steatohepatitis; NET1, Neuroepithelial Cell Transforming 1; NF- ҡB, Nuclear Factor kappa-light-chain-enhancer of activated B cells; NFKBAP, NFKB Activating protein-1; NMDAR, N-methyl-d-aspartate receptor; NPs, Nanoparticles; Non-coding RNAs; Nrf2, Nuclear factor erythroid 2-related factor 2; PDCD4, Programmed cell death protein 4; PFAS, Poly-fluoroalkyl substances; PM2.5, Particulate Matter2.5; RISC, RNA-induced silencing complex; RNA, Ribonucleic acid; RNAi, RNA interference; RNase III, Ribonuclease III; SEMA6D, Semaphorin-6D; SOLiD, Sequencing by Oligonucleotide Ligation and Detection; SPIONs, Superparamagnetic Iron Oxide Nanoparticles; SiO2, Silicon dioxide; TCDD, 2,3,7,8-Tetrachlorodibenzodioxin; TNF-α, Tumor necrosis factor – alpha; TP53, Tumor protein 53; TRBP, Transactivation Response RNA Binding Protein; Toxicity; UTR, Untranslated region; WHO, World Health Organization; Wnt, Wingless-related integration site; ZEA, Zearalanone; Zn, Zinc; bcl2l11, B-cell lymphoma-2-like protein 11; ceRNA, Competing endogenous RNA; lncRNAs, Long non-coding RNA; mRNA, Messenger RNA; miRNA, MicroRNA; qRT-PCR, quantitative Real Time-Polymerase Chain Reaction; ripk 1, Receptor-interacting serine/threonine-protein kinase 1
Year: 2020 PMID: 32426239 PMCID: PMC7225592 DOI: 10.1016/j.toxrep.2020.04.010
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Fig. 1Overview of the miRNA biogenesis, regulation of gene expression and the possible mechanism of xenobiotics in miRNA alteration. Ago2 – Argonaute2; DGCR8 – DiGeorge syndrome chromosomal [or critical] region 8; DROSHA – Ribonuclease III enzyme; GTP – Guanosine triphosphate; mRNA – Messenger RNA; miRNA – microRNA; PACT – Protein kinase RNA activator; POL II/III – RNA Polymerase II/III; POL II – RNA Polymerase II; Pre-miRNA – Precursor microRNA; Pri-miRNA – Primary microRNA; RAN – Ras-related Nuclear protein; RISC – RNA-induced silencing complex; TRBP - Transactivation Response RNA Binding Protein.
In vitro studies with prominently altered miRNAs upon xenobiotic exposure.
| miRNAs | Cell lines | Toxicant | Exposure | Target/s | Effect | Analyses | References |
|---|---|---|---|---|---|---|---|
| miR-200b | HT-29 and HCT-116 | 5-fluorouracil | 10 μM for 6 days | PTPN12 | Alteration in miRNA expression | TaqMan miRNA assay | [ |
| miR-205 | MCF-7 and HepG2 | Nonylphenol | 12 μM and 52 μM for 3 and 48 h | TBX21, GRK7, NHLH1, DNAH9, XCR1, ATP1A4 by miR-205 | Alterations in metabolism and apoptotic genes | Microarray | [ |
| miR-320, miR-494 | Primary murine bronchial epithelial cells | BaP | 0.01 μM, 0.1 μM and 1 μM for 12, 24 and 48 h | CDK6 | Impaired G1 phase | qRT-PCR | [ |
| miR-122, miR-143, miR-379 | Primary rat hepatocytes | Trichostatin A | 25 μM for 2, 4 and 7 days | – | Cell proliferation inhibition. | Microarray | [ |
| miR-29b, miR-26a-1, miR-122 | HepG2 | BaP | 2 μM for 6, 12, 24, and 48 h | BaP-responsive pathway | Apoptosis/DNA Damage Response | Microarray | [ |
| miR-221 | WRL-68 | MC-LR | 10 μg/L for 5, 10, 15, 20, and 25 passages | Cyclin G1 | Tumorigenicity | qRT-PCR and transfection | [ |
| miR-21−3p | HepG2 and HEK 293 T | Berberine chloride | 40 μM for 1, 2, 4 and 8 h | MAT2A and MAT2B | Apoptosis | Microarray | [ |
| miR-197−3p | A549 | Octanal | 0.58 mM for 48 h | MAPK signalling pathway | Increased phosphorylation of p38 MAPK | Microarray and qRT-PCR | [ |
| miR-31, miR-34a, miR-133 | Human Hepatocytes | Rifampicin | 10 μM for 48 h | FOXP1, PDAP1 | Alterations in metabolism genes | Microarray and qRT-PCR | [ |
| miR-2195p, | Jurkat T cell, Jurkat clone E6−1 | Ag NPs and Ag ions | 0.2 mg/L for 24 h | MT1F and TRIB3 by miR-219−5p and ENDOGL1 by miR-654−3p | Oxidative stress, cell cycle and apoptosis | Microarray and qRT-PCR analysis | [ |
| miR-21 | GES-1, AGS, BGC-823, HGC-27, MKN-28, and SGC-7901 | N-nitroso carcinogen N-methyl-N-nitro-N –nitrosoguanidine | 0.1, 0.5, 1.0, 1.5, 2.0, 2.5, or 3.0 μM for 8 h | FASLG and BTG2 | Tumorigenesis | qRT–PCR and Transfection | [ |
| miR-21 | hESC-derived neurons | Research-grade propofol | 0, 5, 10, and 20 μg/mL for 6 h either one time or three times (once per day for 3 consecutive days) | Sprouty 2 | Cell death | qRT-PCR, miRNA transfection | [ |
| miR-210, miR-221 | LNCaP | MIB and DHT | MIB −100 pM DHT −2 nM for 4, 8, 24 and 120 h | AR receptor | Repression of miR-221 and induction of miR-210 | miRNA microarrays and qRT-PCR | [ |
| miR-22 | HepG2 | Bisphenol A | 68 μM for 48 h | NET1 and IL1R1 | Apoptosis | miRNA microarray and qRT-PCR | [ |
| miR-203 | Z310 | Lead | 5, 10 μM for 12 days | TRIC | Pb-induced BCB leakage | qRT-PCR and transfection | [ |
| miR-182,miR-185 | NIH3T3 | PM2.5 | 0.45 mg/mL for 24 h | SLC30A1, SERPINB2, AKR1C1 | Carcinogenesis | Microarray analysis, qRT-PCR and transfection | [ |
| More than 202 miRNAs | Human dermal fibroblasts | AuNPs (size 21.83 ± 4.79 nm) | 200 mM for 1, 4 and 8 h | mRNA processing and MAPK signalling | Alterations in the metabolic process | miRNA sequencing and qRT-PCR | [ |
| 388 miRNAs were altered | PC-12 | SPIONs | 214 μg/mL for 24 h | – | Cell death | SOLiD Sequencing | [ |
| miR-122 | HepaRG | AFB1, AFB2 or BaP | 0, 1, 5, 50, 100, or 200 μM for 24, 48, or 72 h | Inhibition of HNF4A/miR-122 | Carcinogenicity | miRNA profiling and qRT-PCR | [ |
| miR-29b-1, miR-27a | hESC-derived neural cells | Ag NPs | 25 μg/mL for 6 and 24 h | Nrf2 Signalling pathway | Oxidative stress and dysfunctional neurogenesis | Microarray analysis and qRT-PCR | [ |
| miR-222, miR-877 | HepG2 | Vildagliptin | 100 μM for 24 h | Genes involved in cell proliferation and differentiation | Hepatic dysfunction | qRT-PCR | [ |
| 43 miRNAs were altered | Rat astrocytes | Ammonia | 5 mM for 48 h | HO-1 | Astrocyte senescence | Microarray analysis and | [ |
| miR-541 | GC-1 | MC-LR | 500 nM for 24 h | p15, MDM2 | Decreased cell viability and increased apoptosis | qRT-PCR, Dual-luciferase reporter assay | [ |
| miR-155 | Mouse Neuronal cell line | Manganese NPs | 50 μg/mL for 4, 8, 24 and 72 h | TNF-α, IL-6 | Cytotoxicity and ROS | Transfection assay, qRT-PCR | [ |
| miR-222, miR-494 | Lung infiltrating cells | Staphylococcal enterotoxin B | 50 μg for 48 h | CDKN1b, p27kIP1, 2l11 and PUMA | Cell cycle arrest and induction of apoptosis | qRT-PCR and Transfection | [ |
| miR-222, | Chicken ovarian cells | ZnO NPs (30 nm) | 5 μg/mL for 24 h | Genes involved in Wnt, MAPK, mTOR pathway | Adverse effects in the reproductive system | qRT-PCR | [ |
| miR-149−3p, miR-4286 | HepG2 cells | MC-LR | 10 and 50 μM for 24 h | Genes involved in MAPK, Purine and pyrimidine synthesis | Cytotoxicity and hepatitis | qRT-PCR and High throughput sequencing | [ |
| miR-29b3p, | Mouse ovarian granulosa cells | MC-LR | 5 μM for 48 h | GAB2, FOS, IGF1 and MAN1A | Hormone production and cell growth disruption | Microarray and qRT-PCR | [ |
| miR-17−5p | Neuro-2a cells | PQ and MPTP | 300 μM for 48 h | Genes involved in cell cycle and endocytosis | Alteration in cell proliferation, and apoptosis | qRT-PCR, and Microarray | [ |
| miR-431−5p, miR-1229−5p, miR-3648, miR-6126, | A549 cells | Polyhexamethylene guanidine phosphate | 0 to 3 μg/mL for 24 or 48 h | ANKRD29, STC2,CYP4V2 | Epithelial-mesenchymal transition (EMT), cell cycle changes, and apoptosis | qRT-PCR, and Microarray | [ |
| miR-451a, miR-15b-3p and miR-4521 | Human liver cell line | MC-LR | 1, 2.5,5 or 10 μM for 24 h | mTOR, RAS, RAP 1 and HIF-1 | Hepatotoxicity | qRT-PCR | [ |
| miR-200b | Primary human hepatocytes and NHPTK cells | Rifampicin | 10 μM for 24 h | Genes involved in drug metabolizing | Xenobiotic and endobiotic metabolism | qRT-PCR, ChIP-Seq | [ |
| miR-451a | HL7702 | MC-LR | 5 or 10 μM for 24 h | ERK1/2 and p-ERK1/2 | Cytoskeletal damage | qRT-PCR and Transfection | [ |
| miR-200b-3p, | Human primary brain microvascular endothelial cells | Cupric Chloride | 0.5 μM for 48 h | Endothelial LRP1 | Vascular damage | qRT-PCR | [ |
| miR-34a | HepG2 Cells | AgNPs (20 nm), AuNPs and SPIONs | 10 μg/mL AgNPs, 10 μg/mL AuNPs, 5 μg/mL SPIONs for 24 h | TNF | Tumorigenesis | qRT-PCR and methylation analysis | [ |
| miR-222, miR-210, miR-101miR-34a | A549 cells | PM2.5 | 50 μg/mL for 2 h | NRF2 and NFҡB. | Oxidative and inflammation pathway dysfunction | qRT-PCR | [ |
| miR-2861 | Primary mouse spermatocyte cells | Silica NPs | 0 and 5 mg/mL for 30 passages | FADD, CASPASE-8, CASPASE-3, FAS1 | Death receptor pathway dysregulation | Transfection | [ |
| miR-128−3p, | EA. hy926 cell | PM2.5 | 2.5,10 μg/cm2 for 24 h | Genes involved in the focal adhesion pathway | dysfunction of endothelial cells | Microarray and qRT-PCR | [ |
| miR-1303, | SH-SY5Y | Bortezomib | 50 nM for 24 h | DCX, CDK6, ALCAM | Cell proliferation inhibition | Microarray analysis and | [ |
| miR-21−5p, | RPTEC/hTERT and human kidney-2 cells | Cadmium Chloride | 10 mM | Oxidative stress pathway | Nephrotoxicity | miRNA profiling and qRT-PCR | [ |
| miR-689, miR-690, | Hippocampal neuronal cells from new-born C57BL/6 mice | NMDA | 20−30 μM for 10 min | NMDAR signalling | Neural dysfunction | Microarray analysis and qRT-PCR | [ |
| miR-1839−5p,miR-126a-5p, miR-15a | Porcine granulosa cells | ZEN | 30 μM for 48 h | Cell cycle pathway | Growth inhibition and cell cycle arrest | miRNA sequencing and qRT-PCR | [ |
| miR-297 | Human bronchial epithelial cells | Aluminium oxide NPs | 0, 50 and 100 mg/mL for 24 h | NKAP | Pulmonary inflammation | qRT-PCR, miRNA transfection | [ |
Xenobiotics induced miRNA changes in in vivo models.
| miRNA | Model | Toxicant | Exposure | Target | Effect | Analyses | References |
|---|---|---|---|---|---|---|---|
| miR-298, miR-370 | Male Crl(SD)IGS rats | APAP and CCL4 | APAP – 1 g/kg, CCL4 – 0.3 mL/kg for 6 and 24 h | – | Mitochondrial dysfunction | Microarray analysis and | [ |
| miR-26, | Female, virgin B6C3F1 mice | RDX | 5 mg/kg for 28 days | Protooncogene, Oncogene homolog 1 | Neurotoxicity and carcinogenesis | miRNA Microarray and qRT-PCR | [ |
| miR-16, miR-21, miR-146a | Pregnant human females | Cigarette smoking [Nicotine and BaP] | On average, 38 weeks of gestation | BCL2L2, EDA, PLAG1, SATB1, TRAF6 | Alteration in cell cycle regulation and development of the placenta | qRT-PCR | [ |
| miR-430, miR-125, miR-31 | Zebrafish | MC | 12 to 48 mM from 0 hpf to 72 hpf | – | Teratogenic effects | miRNA Microarray and qRT-PCR | [ |
| miR-101a, miR-122 | Male C57BL/6 J strain mice | TCDD | 50 μg/kg, 10 mL/kg b.w for 14 days | COX2, EZH2 | Liver damage | qRT-PCR | [ |
| miR-192, miR-34a, miR-125b, miR-99a – 3p, miR-21 and miR-16 | Female BALB/c Mice | MC | 20 μg/kg b.w/day for 28 days | – | Liver tumorigenesis | miRNA Microarray, qRT-PCR | [ |
| miR-17a, miR-15a, 107, 124, 125b, 203b and 218 | Zebrafish embryos | TCDD | 5 nM for 1 h, at 30 hpf | – | Abnormal developmental phenotypes | Small RNA sequencing and qRT-PCR | [ |
| miR-34c | Crl:CD(SD) rats | DOX | DOX –1 to 3 mg/kg/week for 6 weeks (Intravenous) | SIPA1 | Symptoms of Cardiomyopathy, Cardiotoxicity | Affymetrix assay, qRT-PCR | [ |
| miR-27b | Zebrafish | Crude microcystins | 50, 200, 800 mg/L for 24 h | CYP3A65 and PXR | Hepatotoxicity | qRT-PCR | [ |
| miR-146a | Pregnant women | Bisphenol A | 40 pregnant women from polluted area | Neural and cardiovascular disease genes | Fetal malformations. | Microarray and qRT-PCR | [ |
| miR-575 and miR-4286 | Pregnant women | Lead and Mercury | 60 Mexican women with known exposure | AHR signalling pathway | Reproductive system development, preeclampsia | NanoString nCounter system | [ |
| miR-15a, miR-21, miR-34a, miR-192 | Pigs | ZEA and DON | ZEA - 40 μg/kg/day, | PDCD4, IL10 | Cell proliferation and survival pathway dysregulation | qRT-PCR | [ |
| miR-291a-3p | C57bl/6 mice | Lead acetate | 9.6 mM for 1, 2, and 5 weeks | Uc.173 | Apoptosis of nerve cells | qRT-PCR | [ |
| miR-126−3p | Zebrafish | Atrazine | 0.3, 3, or 30 μg/L from 0 hpf to 72 hpf | ANTXR2 | Angiogenesis and neurodevelopment | Microarray and qRT-PCR | [ |
| miR-541 | BALB/c Mice | MC-LR | 7.5 μg, 15 μg or 30 μg for 2 weeks | p15, MDM2 | Decrease cell viability and increase cell apoptosis | qRT-PCR, Dual-luciferase reporter assay | [ |
| miR-222 miR-494 | C57BL/6 Mice | Staphylococcal enterotoxin B | 50 μg for 48 h | CDKN1b, p27kIP1, BCL2,l11 and PUMA | Cell cycle arrest and induction of apoptosis | qRT-PCR and Transfection | [ |
| miR-200a-3p, miR-5132−5p, miR-5130 | ICR Mice | 300 mg/kg, 375 mg/kg and 450 mg/kg for 24 h | MECP2, RNF165, IFFO2 | Dnaja1 expression alteration | qRT-PCR | [ | |
| miR-208, miR-212, miR-18a | Sprague Dawley Rats | Nanosized SiO2 | 6.25, 12.5, 25 mg/mL and 25 mg/mL for 7 th, 15 th, 30 th, 60 th and 90 th day | PDCD4,LIN28B and CTGF | Alterations in pulmonary hypoplasia, signal pathways of MAPK and TGF-β | qRT-PCR | [ |
| miR-34a, miR-122, | CD-1 mice | Bisphenol A | 25 μg/kg bw/day from gestational day 8 to 4 weeks | NRF2, SREBP-1C | Fat accumulation | qRT-PCR | [ |
| miR-122−3p, miR-194−5p,miR-5099 | ICR and C57BL/6 | 450 mg/kg and 300 mg/kg for 24 h | Genes involved in cellular stress response, cell apoptosis and liver injury | Liver injury | qRT-PCR and Microarray | [][ | |
| miR-126 and miR-155 | Human | Arsenic (inorganic form) | 30.5 ± 25.5 μg/g | Genes involved in vascular homeostasis and inflammatory signalling pathway | Cardiotoxicity | qRT-PCR | [ |
| miR-122 | Wistar albino Rats | Bisphenol A | 0.5 mg/kg, 5 mg/kg and 50 mg/kg for 30 days | JNK, ERK1/2, and MAPKAPK | Oxidative stress and hepatotoxicity | qRT-PCR, Western blotting and Histology | [ |
| miR-153b-3p, miR-19a-3p | Zebrafish | PM2.5 | 0, 25, 50, 100, 200, and 400 μg/mL for 6–120 hpf | CYP3A65, MGST2, GSTP1,GSTO2, GSTO1, CYP1A, EHX1, GSTAl and ALDH3B1 | Alterations in oxidative stress, response to stimuli and metabolic | qRT-PCR and Microarray | [ |
| miR-7147, miR-26a miR-375 | Zebrafish | Si-NPs and MeHg (co-exposure) | 3 mg/mL of Si-NPs and 0.01 mg/mL of MeHg for 24 h | STXBP1A, CELF4, AHR1B and BAI2 | Proinflammatory and cardiovascular toxicity | qRT-PCR and Microarray | [ |
| miR-129−5p, miR-218b, miR-181c | Zebrafish | Si NPs (62 nm) and PbAc (co-exposure) | Si NPs (3 ng/nL) and PbAc (0.5 ng/nL) for 24 h | STXBP1A, NDFIP2, CELF24 and GSK3b | Calcium homeostasis and ER stress | qRT-PCR and Microarray | [ |
| miR-122, miR-151a, miR-192, miR-193a, miR-194, miR-21, miR-29c | Male Sprague Dawley rats | Acetaminophen | 600 or 1200 mg/kg for 6 or 24 h post-treatment | – | Liver injury | qRT-PCR | [ |
| miR-27a | Diclofenac | 0.5, 5, 50, 500 mg/L for 24 and 168 h | P-GP | Dysfunction of detoxification genes | qRT-PCR | [ | |
| miR-33−5q | Hy-Line Brown Chicken | Cadmium chloride | 10 mg/kg for 90 days | NF-kB, p-JNK/JNK, p-AKT/AKT and mTOR | Ion homeostasis disruption | qRT-PCR | [ |
| miR-455−3p | Sprague Dawley Rats | Cadmium chloride | 0.6 mg/kg for 12 weeks | Genes related to cellular signalling pathways | Renal injury | Microarray and qRT-PCR | [ |
| miR-N6, miR-N7, | Ciliate | AgNPs (73.82 nm) | 15 mg/L for 1 and 12 h | p34CDC2 | Increase ROS production, mitochondrial dysfunction | qRT-PCR | [ |
| Let-7b-5p, miR-126−3p, miR16−5p, | Humans (coke oven workers) | 23 urinary metals and ten other urinary OH-PAHs | 0.0004–0.3934 μg/L range and 0.1–0.9 μg/L range | TRIAP1 | Genetic damage and oxidative stress | qRT-PCR | [ |
| miR-205, miR-184 miR-419 | Atrazine | 0.428 μg/L for 8 and 24 h | SOX9, GSDF, DMRT, SMAD4 | Alterations in reproduction process and developmental process | qRT-PCR | [ | |
| miR-125b, miR-125b, miR-155, miR-21 | Silver Carp | [C8mim] Br | 1.095 and 4.380 mg/L for 60 days | Inflammatory pathway | Oxidative stress and inflammation in the fish spleen | qRT-PCR | [ |
| miR-503 | Porcine | ZEA | 0.17 mg/kg, | SPRED1 | Dysregulation of the estrogen response, Wnt and TGF-β1/Smad3 signalling pathways in uterus | qRT-PCR, RNA-Sequence and bioinformatic analyses | [ |
| miR-184, miR-141 | Sprague Dawley rats | Phthalates | 20 μg/kg/day: T1; 200 μg/kg/day: T2; | WNT9b | Delay in prostate development | sncRNAs sequencing | [ |
| miR-35, miR-38, miR-76, miR-354 | 100 nm nanopolystyrene | 1 μg/L from L1-larvae to adult day-3 | – | Alteration in reproduction, development, metabolism, and rhythmic process | SOLiD sequencing, qRT-PCR and RNAi assay | [ | |
| miR-34a-5p, miR-497−5p, miR-34a-5p, miR-34a-5p | Pigs | Ochratoxin A | 50 μg/kg and 200 μg/kg feed for 28 days | CCND1, BCL2, MAP2K1, TNF-α | TP53 signalling network dysregulation | Microarray and qRT-PCR | [ |
| miR-451a | Sprague-Dawley rats | Si NPs | 1.8 mg/kg b.w, 5.4 mg/kg b.w and 16.2 mg/kg b.w for 30 days | IL6R, STAT3, ACSL4l, FOS, TXNDC5 | Alterations in signalling cascades | Immunohistoche-mistry, Western blotting and qRT-PCR | [ |
| miR-367−3p | C57BL/6 mice | 10 mg/kg for 6 and 12 h | – | Liver injury | ChIP analysis, qRT-PCR and Microarray | [ | |
| miR-181a-5p | Zebrafish | Triclosan | 0, 62.5, 125 and 250 mg/L | PAX2Aand VASH2 | Fatty acid biosynthesis and phosphatidylinositol signalling systems | qRT-PCR, Whole-mount | [ |
| miR-24, miR-29a, miR-34a, miR-375 | Wistar Albino rats | Zinc oxide NPs | 5 mg/kg for 15 consecutive days | – | Diabetes development | qRT-PCR | [ |
| miR-223, miR-503, miR-10a, miR-200c | Mouse lungs | Ricin | 7 μg /kg for 24 h | BDP1, CREB5, CCL9, JUN | Changes in inflammatory pathway | qRT-PCR | [ |
| miR-222 | Male BALB/c mice | 40 g/kg for 9 days intraperitoneally | Autophagy pathway | Hepatocyte cell death | Microarray analysis and qRT-PCR | [ | |
| miR-16, miR-181a-3p, miR-223, miR-451 | Silver Carp | MC-LR | 0, 50 μg/kg, 200 μg/kg for 1, 3, 6, 12, 24, and 48 h | Genes involved in cellular, metabolic and single organism process | Multiorgan toxicity | Small RNA sequencing and qRT-PCR | [ |
| miR-155, miR-338, miR-210 | Humans | Arsenic (form not specified) | 0.5−4600 μg/L of arsenic in drinking water | DAPK1, EGR2, APP | Notch signalling pathway impairment | RNA sequencing | [ |
| miR-199a-3, | Carp fish | Cadmium dichloride hemipentahydrate | 0.25 mg/L for 30 days | – | Oxidative stress | RNA sequencing | [ |
| miR-181, miR-291a-3p, miR-493−5p | Sprague Dawley Rats | 2,5-hexanedione | 400 mg/kg/day for 5 weeks | GSK3β, BDNF, MAP1B | Neurotoxicity | Microarray, qRT-PCR and Western blotting | [ |
| miR-181a | (SPF) C57bl/6 Mice | MC-LR | 0, 3 or 15 mg/kg from gestation day 6−19 | GRP78 | Endoplasmic reticulum stress and neuronal apoptosis | Microarray, qRT-PCR and Dual luciferase reporter assay | [ |
Fig. 2Techniques involved in the study of miRNAs. qRT-PCR - quantitative Real Time-Polymerase Chain Reaction; NGS – Next Generation Sequencing; LAMP - loop-mediated isothermal amplification; UTR – Untranslated region; HITS-CLIP – High-throughput sequencing of RNA isolated by crosslinking immunoprecipitation; PAR-CLIP – Photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation.